durapatite has been researched along with Staphylococcal Infections in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (6.35) | 18.7374 |
1990's | 13 (20.63) | 18.2507 |
2000's | 13 (20.63) | 29.6817 |
2010's | 23 (36.51) | 24.3611 |
2020's | 10 (15.87) | 2.80 |
Authors | Studies |
---|---|
Jiang, W; Li, J; Xie, J; Xu, L; Yang, J; Ye, Q; Yuan, H | 1 |
Khosalim, IP; Wong, HM; Yiu, CKY; Zhang, YY | 1 |
Chen, C; Cherian, P; Ebetino, FH; Hu, E; Junka, AF; McKenna, CE; Neighbors, J; Pawlak, J; Roshandel, S; Russell, RGG; Sedghizadeh, PP; Sodagar, E; Sun, S; Tjokro, N | 1 |
Egawa, S; Hirai, K; Matsumoto, R; Okawa, A; Sotome, S; Sugo, K; Yoshii, T; Yuasa, M | 1 |
Biswas, R; Krishnan, AG; Menon, D; Nair, MB | 1 |
Dong, Z; He, J; Huang, J; Li, X; Liu, H; Liu, S; Nie, W; Su, J; Wang, D; Weng, W; Zhou, Q | 1 |
Aizawa, M; Funao, H; Ishihama, H; Ishii, K; Isogai, N; Kakinuma, H; Koyasu, S; Kuramoto, T; Matsumoto, M; Nagai, S; Nakamura, M; Okada, Y; Sasaki, A; Shiono, Y; Toyama, Y; Tsuji, T; Yoshioka, K | 1 |
Akid, R; Callaghan, J; Hatton, PV; Le Maitre, C; Nichol, T; Smith, TJ; Stockley, I; Townsend, R | 1 |
Hashimoto, A; Kii, S; Kobatake, T; Mawatari, M; Miyamoto, H; Noda, I; Shobuike, T; Sonohata, M | 1 |
Alghazali, K; Anderson, DE; Beenken, KE; Biris, AS; Bourdo, SE; Campbell, MJ; Griffin, C; Hecht, S; Jackson, B; King, W; Meeker, DG; Ramirez, AM; Rifkin, R; Smeltzer, MS; Walker, CM | 1 |
da Silva Rigo, EC; de Melo, MP; de Oliveira Vercik, LC; Pugine, SMP; Scatolini, AM | 1 |
Bartoszewicz, M; Chodaczek, G; Czajkowska, J; Duda-Madej, A; Dziadas, M; Fijałkowski, K; Junka, A; Krasowski, G; Mikołajewicz, K; Szymczyk, P; Żywicka, A | 1 |
Büren, C; Oezel, L; Scholz, AO; Windolf, CD; Windolf, J | 1 |
Andrés, J; Assis, M; Beltrán-Mir, H; Cordoncillo, E; Foggi, CC; Longo, E; Macedo, NG; Machado, TR; Martins, TA; Soares da Silva, J | 1 |
Hashimoto, A; Kobatake, T; Mawatari, M; Miyamoto, H; Murakami, T; Nakashima, T; Noda, I; Shobuike, T; Sonohata, M; Ueno, M | 1 |
Doğan, A; Kiremitçi, A; Kose, N; Otuzbir, A; Pekşen, C | 1 |
Abbaspour, A; Alizadeh, AM; Imani Fooladi, AA; Izadi, M; Keshavarz, P; Khodadadi, A; Mohagheghi, MA; Rahimnia, AR; Rezaei, Y; Semeyari, H; Yasui, N | 1 |
Aizawa, M; Honda, M; Ishii, K; Kanzawa, N; Kawanobe, Y; Konishi, T; Matsumoto, M; Mizumoto, M | 1 |
Ferry, T; Flammier, S; Gallet, M; Jurdic, P; Laurent, F; Marvel, J; Nauroy, P; Parroche, P; Rasigade, JP; Trouillet-Assant, S; Vandenesch, F | 1 |
Busscher, HJ; Dijkstra, RJ; Kavanagh, C; Neut, D; Thompson, JI; van der Mei, HC | 1 |
Brooks, AE; Brooks, BD; Grainger, DW; Sinclair, KD | 1 |
Fernandes, MH; Ferraz, MP; Grenho, L; Monteiro, FJ; Salgado, CL | 1 |
Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF | 1 |
Fu, Q; Huang, WH; Jia, WT; Rahaman, MN; Zhang, CQ | 1 |
Albayati, ZA; Breen, PJ; Crooks, PA; Karau, MJ; Merten, KE; Morris, AJ; Patel, R; Pierce, WM; Schmidt-Malan, SM; Smeltzer, MS; Steckelberg, JM; Sunkara, M; Taylor, KG | 1 |
Cao, Z; Jiang, D; Wu, J; Yan, L | 1 |
Fan, XY; He, XQ; Jin, T; Li, Y; Wang, H; Wang, Y; Xu, YQ | 1 |
Baino, F; Bollati, D; Cassinelli, C; Iviglia, G; Morra, M; Torre, E; Vitale-Brovarone, C | 1 |
Hearst, MJ; Kerr, RG; Pensak, ML; Samy, RN; Tew, JM; Theodosopoulos, PV; van Loveren, HR | 1 |
Dong, YX; Nie, YD; Pan, CJ; Wang, YL; Zhang, YY; Zhao, CH | 1 |
Dong, J; Fang, TL; Jiang, JL; Li, XL; Li, YF; Wang, YC; Zhou, J | 1 |
Aalbæk, B; Dahl-Petersen, K; Frees, D; Heegaard, PM; Iburg, TM; Jensen, HE; Johansen, LK; Koch, J; Leifsson, PS; Nielsen, OL | 1 |
Fan, X; Huang, J; Ma, T; Tang, H; Xu, Y | 1 |
Kaewsrichan, J; Thanyaphoo, S | 1 |
Calhoun, JH; Mader, JT; Shirtliff, ME | 1 |
Buranapanitkit, B; Geater, A; Ingviga, N; Oungbho, K; Ovatlarnporn, C; Srinilta, V | 1 |
Brandt, B; Gosheger, G; Joist, A; Joosten, U; Liljenqvist, U; von Eiff, C | 1 |
di Silvio, L; Heliotis, M; Lavery, KM; Ripamonti, U; Tsiridis, E | 1 |
Itokazu, M; Matsumoto, K; Naganawa, T; Shimizu, K; Takigami, I; Uemura, S | 1 |
Bostrom, M; Gardner, M; Griffith, M; Wanich, T; Zelken, J | 1 |
Bergemer-Fouquet, AM; Besnier, JM; Damie, F; Favard, L; Laure, B; Marquet-Van Der Mee, N; Quentin, R; Rosset, P | 1 |
Alvarez, H; Castro, C; Delgado, A; Evora, C; Moujir, L; Perera, A; Sánchez, E; Soriano, I | 1 |
Ellman, MH | 1 |
Glatt, HJ | 1 |
Ainbinder, DJ; Haik, BG; Tellado, M | 1 |
Araki, N; Inoue, K; Korkusuz, F; Ono, K; Shinto, Y; Uchida, A | 1 |
Asai, T; Nagaya, I; Shinjo, K; Tukamoto, M | 1 |
Glasgow, BJ; Goldberg, RA; Shorr, N; Weinberg, DA | 1 |
Brownstein, S; Jolly, SS; Jordan, DR | 1 |
Brownstein, S; Jordan, DR; Klapper, SR; Mawn, L; Punja, K | 1 |
Arciola, CR; Donati, ME; Giordano, M; Montanaro, L; Moroni, A; Pizzoferrato, A | 1 |
Baumgaertner, MR; Gutow, AP; Solberg, BD | 1 |
McKelvie, P; McNab, AA; Sloan, BH | 1 |
Itokazu, M; Kumazawa, S; Matsunaga, T; Oka, M | 1 |
Johnson, PJ; Lydiatt, WM; Moore, GF; Robbins, DL | 1 |
Bottoni, CR; Brooks, DE; Campbell, AA; DeBerardino, TM; DeJong, ES; Guymon, CH; McManus, AT; Nelson, BJ; Pusateri, AE; Walton, RS | 1 |
Dhert, WJ; Fleer, A; Nijhof, MW; Oosterbos, CJ; Tonino, AJ; Verbout, AJ; Vogely, HCh | 1 |
Anegawa, S; Mitsukawa, N; Suse, T; Uemura, T; Yokoyama, T; Yoshikawa, A | 1 |
Ebrahimpour, J; Goldberg, RA; Holds, JB | 1 |
Rosen, HM | 1 |
Daems, WT; de Groot, K; Grote, JJ; Kuijpers, W; van Blitterswijk, CA | 1 |
Bakker, D; Daems, WT; Grote, JJ; van Blitterswijk, CA | 1 |
Grote, JJ; Koerten, HK; Kuijpers, W; van Blitterswijk, CA | 1 |
63 other study(ies) available for durapatite and Staphylococcal Infections
Article | Year |
---|---|
An injectable gellan gum-based hydrogel that inhibits
Topics: Animals; Anti-Bacterial Agents; Biofilms; Bone and Bones; Bone Diseases, Infectious; Chlorhexidine; Durapatite; Hydrogels; Male; Nanoparticles; Polysaccharides, Bacterial; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Tissue Engineering; Tissue Scaffolds; Wound Healing | 2022 |
Synthesis of a graphene oxide/agarose/hydroxyapatite biomaterial with the evaluation of antibacterial activity and initial cell attachment.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Cell Survival; Durapatite; Graphite; Humans; Nanoparticles; Sepharose; Staphylococcal Infections; Staphylococcus aureus; Tissue Engineering | 2022 |
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Diphosphonates; Durapatite; Electric Impedance; Etidronic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Efficacy of Antibiotic-Loaded Hydroxyapatite/Collagen Composites Is Dependent on Adsorbability for Treating Staphylococcus aureus Osteomyelitis in Rats.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Bone Regeneration; Cefazolin; Collagen; Drug Evaluation, Preclinical; Drug Implants; Durapatite; Male; Osteomyelitis; Rats, Wistar; Staphylococcal Infections; Vancomycin | 2020 |
Biodegradable nanocomposite fibrous scaffold mediated local delivery of vancomycin for the treatment of MRSA infected experimental osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Drug Delivery Systems; Durapatite; Gelatin; Male; Methicillin-Resistant Staphylococcus aureus; Nanocomposites; Osteomyelitis; Polyesters; Rats, Wistar; Silicon Dioxide; Staphylococcal Infections; Vancomycin | 2020 |
One-Step Preparation of an AgNP-nHA@RGO Three-Dimensional Porous Scaffold and Its Application in Infected Bone Defect Treatment.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Bone and Bones; Bone Diseases, Infectious; Bone Regeneration; Bone Substitutes; Disease Models, Animal; Durapatite; Female; Graphite; Male; Materials Testing; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Porosity; Rabbits; Rats; Silver; Staphylococcal Infections; Tissue Engineering; Tissue Scaffolds | 2020 |
An antibacterial coated polymer prevents biofilm formation and implant-associated infection.
Topics: Animals; Anti-Bacterial Agents; Benzophenones; Biofilms; Coated Materials, Biocompatible; Durapatite; Humans; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Mice; Polymers; Prostheses and Implants; Reactive Oxygen Species; Silver; Staphylococcal Infections | 2021 |
The antimicrobial activity and biocompatibility of a controlled gentamicin-releasing single-layer sol-gel coating on hydroxyapatite-coated titanium.
Topics: Animals; Biofilms; Coated Materials, Biocompatible; Durapatite; Gentamicins; Materials Testing; Prosthesis-Related Infections; Rats; Staphylococcal Infections; Titanium | 2021 |
Time-dependent efficacy of combination of silver-containing hydroxyapatite coating and vancomycin on methicillin-resistant Staphylococcus aureus biofilm formation in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Durapatite; Humans; Methicillin-Resistant Staphylococcus aureus; Silver; Staphylococcal Infections; Vancomycin | 2021 |
Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Regeneration; Disease Models, Animal; Drug Delivery Systems; Durapatite; Gentamicins; Osteogenesis; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds; Vancomycin; X-Ray Microtomography | 2021 |
Evaluation of the antimicrobial activity and cytotoxic effect of hydroxyapatite containing Brazilian propolis.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; CHO Cells; Cricetulus; Durapatite; Ethanol; Flavonoids; Inhibitory Concentration 50; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Plant Extracts; Powders; Propolis; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Potential of Biocellulose Carrier Impregnated with Essential Oils to Fight Against Biofilms Formed on Hydroxyapatite.
Topics: Anti-Bacterial Agents; Biofilms; Cellulose; Durapatite; Eucalyptus; Humans; Oils, Volatile; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Syzygium; Thymus Plant | 2019 |
Effect of antibiotic infused calcium sulfate/hydroxyapatite (CAS/HA) insets on implant-associated osteitis in a femur fracture model in mice.
Topics: Animals; Anti-Bacterial Agents; Bone Plates; Calcium Sulfate; Disease Models, Animal; Durapatite; Female; Femoral Fractures; Fracture Healing; Mice; Mice, Inbred BALB C; Osteitis; Staphylococcal Infections; Staphylococcus aureus | 2019 |
α-AgVO
Topics: Anti-Bacterial Agents; Biocompatible Materials; Chemical Precipitation; Durapatite; Humans; Luminescence; Luminescent Agents; Models, Molecular; Nanotubes; Silver; Staphylococcal Infections; Staphylococcus aureus; Vanadates | 2019 |
Antibacterial Activity of Ag-Hydroxyapatite Coating Against Hematogenous Infection by Methicillin-Resistant Staphylococcus aureus in the Rat Femur.
Topics: Animals; Anti-Bacterial Agents; Coated Materials, Biocompatible; Durapatite; Femur; Male; Methicillin-Resistant Staphylococcus aureus; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Silver; Staphylococcal Infections | 2019 |
A silver ion-doped calcium phosphate-based ceramic nanopowder-coated prosthesis increased infection resistance.
Topics: Alloys; Animals; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Calcium Phosphates; Coated Materials, Biocompatible; Delayed-Action Preparations; Disease Models, Animal; Durapatite; Knee Prosthesis; Nanomedicine; Nanoparticles; Powders; Prosthesis Design; Prosthesis-Related Infections; Rabbits; Radiography; Silver; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Titanium | 2013 |
Antibiotic-coated pins for prevention of pin-tract infection: a rabbit study.
Topics: Animals; Anti-Bacterial Agents; Bone Nails; Coated Materials, Biocompatible; Disease Models, Animal; Durapatite; Male; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 2013 |
In vitro and in vivo antimicrobial properties of silver-containing hydroxyapatite prepared via ultrasonic spray pyrolysis route.
Topics: Animals; Anti-Infective Agents; Biofilms; Calcium; Cell Line; Cell Proliferation; Coated Materials, Biocompatible; Durapatite; Ions; Luminescent Measurements; Male; Materials Testing; Mice; Mice, Inbred BALB C; Osteoblasts; Prostheses and Implants; Silver; Sonication; Staphylococcal Infections; Staphylococcus aureus | 2013 |
Dual impact of live Staphylococcus aureus on the osteoclast lineage, leading to increased bone resorption.
Topics: Adhesins, Bacterial; Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Cytokines; Durapatite; Host-Pathogen Interactions; Mice; Models, Biological; Osteoclasts; Staphylococcal Infections; Staphylococcus aureus | 2015 |
A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Bone Nails; Coated Materials, Biocompatible; Dogs; Drug Resistance, Bacterial; Durapatite; Female; Femur; Gentamicins; Hip Prosthesis; Lactic Acid; Male; Microscopy, Electron, Scanning; Osseointegration; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Treatment Outcome | 2015 |
A resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect model.
Topics: Animals; Anti-Bacterial Agents; Bone Substitutes; Calcium Carbonate; Ceramics; Durapatite; Perioperative Period; Polymers; Prosthesis-Related Infections; Rabbits; Radiography; Radius; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2015 |
Antibacterial activity and biocompatibility of three-dimensional nanostructured porous granules of hydroxyapatite and zinc oxide nanoparticles--an in vitro and in vivo study.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Cell Line; Durapatite; Humans; In Vitro Techniques; Male; Nanoparticles; Nanopores; Osteoblasts; Porosity; Rats; Rats, Wistar; Staphylococcal Infections; Zinc Oxide | 2015 |
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carriers; Durapatite; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.
Topics: Animals; Anti-Bacterial Agents; Boron Compounds; Calcium Sulfate; Disease Models, Animal; Drug Carriers; Drug Implants; Durapatite; Female; Glass; Injections, Intralesional; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rabbits; Staphylococcal Infections; Teicoplanin; Tibia; Treatment Outcome | 2015 |
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Debridement; Disease Models, Animal; Drug Carriers; Durapatite; Humans; Osteomyelitis; Polyethylene Glycols; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
In vitro and in vivo osteogenic activity of the novel vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) scaffold.
Topics: Animals; Anti-Bacterial Agents; Bone Substitutes; Cell Line; Drug Carriers; Durapatite; Humans; Osteoblasts; Osteogenesis; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds; Vancomycin | 2016 |
Wnt11 plays an important role in the osteogenesis of human mesenchymal stem cells in a PHA/FN/ALG composite scaffold: possible treatment for infected bone defect.
Topics: Adult; Alginates; Animals; Bone Regeneration; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cells, Cultured; Culture Media; Durapatite; Female; Fibronectins; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Osteogenesis; Osteomyelitis; Rabbits; Radiography; Regenerative Medicine; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tissue Engineering; Tissue Scaffolds; Transfection; Wnt Proteins | 2016 |
Engineered porous scaffolds for periprosthetic infection prevention.
Topics: Animals; Calcium Phosphates; Cell Line; Chitosan; Delayed-Action Preparations; Durapatite; Implants, Experimental; Mice; Osteoblasts; Pectins; Porosity; Staphylococcal Infections; Staphylococcus epidermidis; Tissue Scaffolds; Vancomycin | 2016 |
Delayed extrusion of hydroxyapatite cement after transpetrosal reconstruction.
Topics: Adult; Aged; Bone Cements; Durapatite; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Male; Middle Aged; Petrous Bone; Plastic Surgery Procedures; Retrospective Studies; Staphylococcal Infections; Young Adult | 2009 |
Enhancing the antibacterial activity of biomimetic HA coatings by incorporation of norvancomycin.
Topics: Biomimetic Materials; Coated Materials, Biocompatible; Durapatite; Humans; Joint Prosthesis; Materials Testing; Prosthesis Design; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Surface Properties | 2011 |
Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Carriers; Drug Implants; Durapatite; Methicillin-Resistant Staphylococcus aureus; Nanostructures; Osteomyelitis; Rabbits; Radiography; Staphylococcal Infections; Tibia; Vancomycin | 2012 |
Local osteogenic expression of cyclooxygenase-2 and systemic response in porcine models of osteomyelitis.
Topics: Alkaline Phosphatase; Animals; Cyclooxygenase 2; Durapatite; Haptoglobins; Immunohistochemistry; Models, Animal; Osteoblasts; Osteomyelitis; Staphylococcal Infections; Swine | 2012 |
[Vancomycin cationic liposome combined with nano-hydroxyapatite/chitosan/konjac glucomannan scaffold for treatment of infected bone defects in rabbits].
Topics: Animals; Bone Diseases; Bone Regeneration; Chitosan; Chronic Disease; Durapatite; Liposomes; Mannans; Nanostructures; Osteomyelitis; Rabbits; Staphylococcal Infections; Tissue Scaffolds; Vancomycin | 2012 |
Synthesis and evaluation of novel glass ceramics as drug delivery systems in osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Substitutes; Cell Line; Cell Survival; Ceramics; Drug Delivery Systems; Durapatite; Humans; Osteomyelitis; Rats; Silicon Dioxide; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2012 |
Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Colony Count, Microbial; Drug Delivery Systems; Durapatite; Female; Osteomyelitis; Polymethyl Methacrylate; Prostheses and Implants; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tibia; Vancomycin | 2002 |
The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Calcium Sulfate; Chitin; Chitosan; Drug Carriers; Durapatite; Microscopy, Electron, Scanning; Staphylococcal Infections | 2004 |
Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Topics: Animals; Biological Availability; Body Weight; Bone Cements; C-Reactive Protein; Chronic Disease; Disease Models, Animal; Drug Carriers; Durapatite; Leukocyte Count; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Transformation of a prefabricated hydroxyapatite/osteogenic protein-1 implant into a vascularised pedicled bone flap in the human chest.
Topics: Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Carcinoma, Squamous Cell; Durapatite; Graft Survival; Humans; Male; Mandible; Methicillin Resistance; Middle Aged; Mouth Neoplasms; Osteogenesis; Pectoralis Muscles; Plastic Surgery Procedures; Staphylococcal Infections; Surgical Flaps; Surgical Wound Infection; Transforming Growth Factor beta | 2006 |
Successful joint arthroplasty after treatment of destructive MRSA arthritis of the knee using antibiotic-loaded hydroxyapatite blocks: a case report.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Biocompatible Materials; Durapatite; Female; Humans; Knee Joint; Methicillin Resistance; Radiography; Staphylococcal Infections; Vancomycin | 2007 |
PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Colony Count, Microbial; Disease Models, Animal; Drug Carriers; Durapatite; Female; Microbial Viability; Osteomyelitis; Polymethacrylic Acids; Radiography; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Tibia; Treatment Outcome; Vancomycin | 2007 |
Effect of hydroxyapatite coating and polymethylmethacrylate on stainless steel implant-site infection with Staphylococcus epidermidis in a sheep model.
Topics: Animals; Bone and Bones; Disease Models, Animal; Durapatite; Polymethyl Methacrylate; Prostheses and Implants; Sheep; Stainless Steel; Staphylococcal Infections; Staphylococcus epidermidis; Synovial Membrane | 2008 |
Efficacy of ciprofloxacin implants in treating experimental osteomyelitis.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Biocompatible Materials; Blood Platelets; Body Weight; Calcium Phosphates; Ciprofloxacin; Disease Models, Animal; Durapatite; Femur; Gamma Rays; Humans; Implants, Experimental; Leukocytes; Male; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Diagnosis and management of bursitis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bursitis; Chondrocalcinosis; Colchicine; Durapatite; Gout; Humans; Hydroxyapatites; Ibuprofen; Indomethacin; Knee; Shoulder; Staphylococcal Infections; Wounds and Injuries | 1984 |
Exposed hydroxyapatite implants.
Topics: Conjunctival Diseases; Durapatite; Eye Infections, Bacterial; Humans; Orbital Diseases; Postoperative Complications; Prostheses and Implants; Staphylococcal Infections; Surgical Wound Dehiscence | 1995 |
Hydroxyapatite orbital implant abscess: histopathologic correlation of an infected implant following evisceration.
Topics: Abscess; Durapatite; Eye Infections, Bacterial; Fibrosis; Humans; Male; Middle Aged; Orbit Evisceration; Orbital Diseases; Prostheses and Implants; Staphylococcal Infections; Surgical Wound Dehiscence | 1994 |
Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites.
Topics: Animals; Ceramics; Drug Carriers; Durapatite; Female; Gentamicins; Hydroxyapatites; Injections, Intraperitoneal; Microscopy, Electron, Scanning; Osteomyelitis; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus | 1993 |
[One stage operation for dead space of pyogenic and tuberculous osteomyelitis].
Topics: Adult; Biocompatible Materials; Durapatite; Female; Fibrin Tissue Adhesive; Follow-Up Studies; Humans; Male; Middle Aged; Orthopedics; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Suppuration; Tuberculosis, Osteoarticular | 1993 |
Draining cutaneous fistula associated with infection of hydroxyapatite orbital implant.
Topics: Adult; Anophthalmos; Biocompatible Materials; Cutaneous Fistula; Drainage; Durapatite; Eye Infections, Bacterial; Eyelid Diseases; Female; Humans; Necrosis; Orbit; Prostheses and Implants; Staphylococcal Infections; Staphylococcus aureus | 1996 |
Abscessed hydroxyapatite orbital implants. A report of two cases.
Topics: Abscess; Aged; Aged, 80 and over; Conjunctiva; Durapatite; Eye Enucleation; Eye Infections, Bacterial; Female; Granuloma, Pyogenic; Humans; Male; Middle Aged; Orbit; Orbital Diseases; Prostheses and Implants; Staphylococcal Infections; Staphylococcus aureus | 1996 |
Abscess formation within a synthetic hydroxyapatite orbital implant.
Topics: Abscess; Adult; Anti-Bacterial Agents; Choroid Neoplasms; Drug Therapy, Combination; Durapatite; Eye Enucleation; Eye Infections, Bacterial; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Melanoma; Orbital Implants; Prosthesis-Related Infections; Reoperation; Staphylococcal Infections; Staphylococcus epidermidis | 1998 |
Hydroxyapatite-coated orthopaedic screws as infection resistant materials: in vitro study.
Topics: Bacterial Adhesion; Bone Screws; Calcium; Coated Materials, Biocompatible; Durapatite; Stainless Steel; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors | 1999 |
Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Biodegradation, Environmental; Bone Cements; Chronic Disease; Disease Models, Animal; Drug Implants; Durapatite; Female; Gentamicins; Osteomyelitis; Rats; Rats, Sprague-Dawley; Reference Values; Staphylococcal Infections; Treatment Outcome | 1999 |
Late infection of hydroxyapatite orbital implants.
Topics: Aged; Chronic Disease; Durapatite; Eye Infections, Bacterial; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Orbit; Orbit Evisceration; Orbital Implants; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus | 1999 |
Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block.
Topics: Adolescent; Alcaligenes; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Delivery Systems; Durapatite; Female; Hip Prosthesis; Humans; Male; Middle Aged; Osteomyelitis; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Tuberculosis | 1994 |
Salvage of an infected hydroxyapatite cement cranioplasty with preservation of the implant material.
Topics: Adult; Anti-Bacterial Agents; Bone Cements; Candidiasis; Craniotomy; Durapatite; Female; Follow-Up Studies; Humans; Meniere Disease; Plastic Surgery Procedures; Prosthesis Implantation; Reoperation; Staphylococcal Infections; Surgical Flaps; Surgical Wound Infection; Treatment Outcome | 2000 |
Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/chlorhexidine complex to prevent pin tract infection in a goat model.
Topics: Animals; Anti-Infective Agents, Local; Bone Nails; Chi-Square Distribution; Chlorhexidine; Coated Materials, Biocompatible; Device Removal; Disease Models, Animal; Durapatite; External Fixators; Fracture Fixation; Goats; Male; Stainless Steel; Staphylococcal Infections; Statistics, Nonparametric; Tibial Fractures; Titanium; Torque | 2001 |
Osseointegration of hydroxyapatite-coated and noncoated Ti6Al4V implants in the presence of local infection: a comparative histomorphometrical study in rabbits.
Topics: Alloys; Animals; Biocompatible Materials; Durapatite; Female; Osseointegration; Prostheses and Implants; Rabbits; Staphylococcal Infections; Tibia; Titanium | 2002 |
Staged cranial reconstruction after epidural abscess associated with dural substitute exposure.
Topics: Biocompatible Materials; Bone Substitutes; Bone Transplantation; Ceramics; Chronic Disease; Device Removal; Dura Mater; Durapatite; Epidural Abscess; Fascia Lata; Follow-Up Studies; Humans; Male; Methicillin Resistance; Middle Aged; Polytetrafluoroethylene; Prosthesis-Related Infections; Rectus Abdominis; Skin Ulcer; Staphylococcal Infections; Surgical Wound Infection; Transplantation, Autologous | 2002 |
Exposed hydroxyapatite orbital implants. Report of six cases.
Topics: Adolescent; Adult; Child, Preschool; Conjunctival Diseases; Durapatite; Eye Infections, Bacterial; Humans; Hydroxyapatites; Male; Orbital Diseases; Postoperative Complications; Prostheses and Implants; Staphylococcal Infections; Surgical Wound Dehiscence | 1992 |
The response of porous hydroxyapatite to contiguous tissue infection.
Topics: Adolescent; Adult; Durapatite; Female; Fistula; Gram-Positive Bacterial Infections; Humans; Hydroxyapatites; Mandibular Prosthesis; Maxillary Sinusitis; Maxillofacial Prosthesis; Mouth Diseases; Porosity; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes | 1991 |
The biological performance of calcium phosphate ceramics in an infected implantation site: I. Biological performance of hydroxyapatite during Staphylococcus aureus infection.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Durapatite; Ear, Middle; Epithelium; Hydroxyapatites; Otitis Media; Phagocytes; Prostheses and Implants; Rats; Staphylococcal Infections; Wound Infection | 1986 |
The biological performance of calcium phosphate ceramics in an infected implantation site: II. Biological evaluation of hydroxyapatite during short-term infection.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Durapatite; Ear, Middle; Hydroxyapatites; Male; Otitis Media; Phagocytosis; Prostheses and Implants; Rats; Rats, Inbred Strains; Staphylococcal Infections; Time Factors; Wound Infection | 1986 |
The biological performance of calcium phosphate ceramics in an infected implantation site. III: Biological performance of beta-whitlockite in the noninfected and infected rat middle ear.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Calcium Phosphates; Durapatite; Epithelium; Hydroxyapatites; Male; Ossicular Prosthesis; Otitis Media; Rats; Staphylococcal Infections | 1986 |